Review Article

Comparison of Amino Acid PET to Advanced and Emerging MRI Techniques for Neurooncology Imaging: A Systematic Review of the Recent Studies

Table 2

Summary of aaPET with PWI studies.

StudyYearStudy locationNo. of patientsaaPETPWITumor typeMain results

Beppu et al. [56]2019Morioka, Japan24METASLRecurrent GBMModalities were significantly correlated before and after treatment. ASL PWI reliably predicted survival, but MET PET was more accurate.
Pala et al. [57]2019Günzburg, Germany18METDSCGBMMET PET is more sensitive than PWI DSC for residual tumor detection. PWI DSC cannot substitute MET PET in tumor detection.
Qiao et al. [58]2019Beijing, China42METDSCHigh-grade gliomaBoth could accurately differentiate radiation injury from recurrence. Combined, they yielded the best accuracy.
Roodakker et al. [39]2019Uppsala, Sweden4METDSCOligodendrogliomaMET PET could identify tumor cell density, but PWI DSC could not. The modalities were not significantly correlated.
Lundemann et al. [49]2019Copenhagen, Denmark16FETDCEPretreatment GBMFET PET had the highest predictive value for recurrence. Combined parameters could map the probability of recurrence.
Dissaux et al. [59]2020Brest, France30FETDSCHigh-grade gliomaPWI DSC is highly correlated with standard MRI, but FET PET provides complementary data.
Verburg et al. [52]2020Amsterdam, Netherlands20FETASL, DSCNewly diagnosed nonenhancing gliomaFET PET with PWI DSC together could diagnose IDH-mutant glioma.
Schon et al. [60]2020Munich, Germany46FETDSCNewly diagnosed gliomaBoth modalities could identify vascularity, but only FET PET could identify cellularity.
Fraioli et al. [61]2020London, UK40FDOPADSCGliomaBoth could differentiate tumor, but performed better when combined. FDOPA PET distinguished more features.
Tatekawa et al. [53]2020Los Angeles, USA61FDOPADSCTreatment-naïve gliomaPositively correlated in IDH-wt and IDH-mutant-1p/19q-non-codeleted. Not correlated in IDH-mutant-codeleted.
John et al. [62]2019Detroit, USA20AMTDSCGBMModerate correlation between modalities in nonenhancing tumor regions.